Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00456001 · ClinicalTrials.gov registry record
Heparin Induced Thrombocytopenia: Pharmacoeconomics
A clinical trial of Heparin Induced Thrombocytopenia (HIT), sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT00456001: Completed study of Heparin Induced Thrombocytopenia (HIT), sponsored by Brigham and Women's Hospital.
NCT00456001 is a study of Heparin Induced Thrombocytopenia (HIT) that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00456001, a study of Heparin Induced Thrombocytopenia (HIT), has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients at BWH receiving unfractionated heparin or enoxaparin who subsequently develop heparin induced thrombocytopenia will be identified via a computer generated report designed for the purposes of this study. Subsequently, we will compare the heparin induced thrombocytopenia rates associated with heparin and low molecular weight heparin usage as well as evaluate the economic and long-term clinical burden of heparin induced thrombocytopenia.
Conditions Studied
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-07 |
| Est. Completion | 2009-01 |
What the finished NCT00456001 record still lists
NCT00456001 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Heparin Induced Thrombocytopenia (HIT) appearing as the primary indexed condition, and to 0 interventions.
NCT00456001 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00456001 about?
NCT00456001 is a clinical study titled "Heparin Induced Thrombocytopenia: Pharmacoeconomics". Patients at BWH receiving unfractionated heparin or enoxaparin who subsequently develop heparin induced thrombocytopenia will be identified via a computer generated report designed for the purposes of this study. Subsequently, we will compare the heparin induced thrombocytopenia rates associated wi...
What is the current status of trial NCT00456001?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2006-07. Estimated completion is 2009-01.
What conditions does trial NCT00456001 study?
This clinical trial studies the following conditions: Heparin Induced Thrombocytopenia (HIT).
Who is sponsoring clinical trial NCT00456001?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00456001 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia